SCHEMBL8143134

SCHEMBL8143134

CC(C)(C)OC(=O)C1CCCN1c1ccc([N+](=O)[O-])c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.41
LMNA P02545 3/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CASP3 P42574 1/20 0.40
SERPINE1 P05121 2/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
CNR2 P34972 2/20 0.38
CYP2C8 P10632 1/20 0.38
CNR1 P21554 1/20 0.38
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8143132 1.00 MAPT (0.41) MAPTLMNAMAPK1ALDH1A1CASP3
SCHEMBL4714684 0.83 MAPT (0.53) MAPTLMNAMAPK1ALDH1A1CASP3
SCHEMBL7493247 0.83 MAPT (0.56) MAPTMAPK1ALDH1A1SERPINE1CYP2C19
SCHEMBL7493258 0.83 MAPT (0.56) MAPTMAPK1ALDH1A1SERPINE1CYP2C19
SCHEMBL7489599 0.75 BACE1 (0.44) MAPTLMNAALDH1A1SERPINE1CYP2C9
SCHEMBL5264109 0.75 CASP3 (0.41) LMNACASP3CYP2C9CYP2C19CYP2D6
SCHEMBL28690247 0.75 CASP3 (0.41) CASP3CYP2C9CYP2C19CYP2D6CNR2
SCHEMBL77428 0.75 CASP3 (0.41) LMNACASP3CYP2C9CYP2C19CYP2D6
SCHEMBL10316029 0.74 GPR119 (0.60) MAPTLMNAALDH1A1
SCHEMBL5863476 0.74 MAPT (0.39) MAPTLMNAMAPK1ALDH1A1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6011059-A PREVENTING OR TREATING ANGINA PECTORIS, CARDIAC DYSFUNCTION, MYOCARDIAL NECROSIS, AND ARRHYTHMIA EMPLOYING THE ABOVE ACYL GUANIDINES. BRISTOL-MYERS SQUIBB COMPANY (US) 2000-01-04 US disclosed